Purchase Order 36C26024P0312

Award Date 2/8/24
Potential Completion Date 2/7/25
Potential Value $50K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Walla Walla, WA 99362, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Novocure Inc., a foreign-owned, for-profit medical device manufacturer, is for the provision of the Optune device, a specialized cancer therapy technology utilizing Tumor Treating Fields (TTFields). The contract, awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA), has a ceiling value of $49,748.73 and is structured as a firm fixed-price purchase order with a completion date of July 16, 2025. Novocure holds a significant...
This federal contract award to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices, is for the provision of the company's Optune line of Tumor Treating Fields (TTFields) therapy devices, transducer arrays, rental equipment, and associated support services to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The award, valued at $45,600.00, is a Firm Fixed Price Purchase Order with a period of performance through February 28, 2025. The...
This federal contract award to Novocure Inc., a foreign-owned, for-profit medical device manufacturer, provides the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) with Novocure's Optune Plus transducer devices and associated support services. The $33,165.82 firm fixed-price delivery order was issued under Novocure's 5-year, $28.85 million Federal Supply Schedule (FSS) contract with the VA VHA, awarded in November 2022. This contract enables the VA to efficiently...
This is a federal contract award to Novocure Inc., a foreign-owned, for-profit medical device manufacturer, by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The contract, with a ceiling value of $49,748.73, is for the delivery of Novocure's Optune system, a non-invasive cancer therapy technology that utilizes Tumor Treating Fields (TTFields) to disrupt solid tumor cancer cell division. This is a firm fixed-price purchase order contract with a period of...
This federal contract award to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The $49,748.73 delivery order contract is for the provision of Novocure's Optune line of Tumor Treating Fields (TTFields) therapy devices, transducer arrays, rental equipment, and associated support services. The contract is part of a larger $28.85 million Federal Supply Schedule (FSS)...
This federal contract award is for the procurement of Optune Plus transducers from Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices specializing in cancer therapy. The $16,582.91 firm-fixed price purchase order was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc. as the prime contractor. The contract has an ultimate completion date of March 28, 2025 and does not utilize any set-aside designations. Novocure...
This federal contract award is for the delivery of Novocure Inc.'s Optune Plus transducers to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) for a 3-month period. The contract, valued at $49,748.73, was awarded on September 9, 2024 as a firm-fixed price purchase order with an ultimate completion date of October 31, 2024. Novocure, a foreign-owned, for-profit manufacturer of medical devices, is providing its proprietary Optune system which delivers alternating...
This federal contract award is for the provision of Novocure Inc.'s Optune Plus Transducer Therapy System to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). Novocure, a foreign-owned, for-profit manufacturer of medical devices, is the prime contractor on this $49,748.73 firm-fixed-price delivery order contract. The contract, which does not utilize any set-aside designations, was awarded on March 27, 2024, with a period of performance through June 26, 2024....
This federal contract award to Novocure Inc., a foreign-owned, for-profit medical device manufacturer, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The $33,165.82 firm fixed-price purchase order is for the delivery of Novocure's Optune medical device system, including transducers, rental equipment, and associated support services. The contract does not utilize a set-aside designation, likely due to the specialized nature of Novocure's cancer...
This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned for-profit medical device manufacturer. The contract, valued at $49,748.73, is for the provision of Novocure's Optune Plus Transducers, a cancer therapy product utilizing Tumor Treating Fields (TTFields) technology. The contract does not have a set-aside designation and is part of Novocure's 5-year, $28.85 million Federal...

This is a federal contract award to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices, by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The contract, valued at $49,748.73, is for the provision of Novocure's Optune Plus electronic stimulation cancer treatment devices and associated services. The contract is a firm-fixed-price purchase order with a performance period extending to February 7, 2025. Novocure delivers its proprietary Optune TTFields therapy products directly to VA medical centers nationwide without the use of subcontractors. This award is not associated with any set-aside designations. Novocure holds a $28.85 million Federal Supply Schedule (FSS) contract with the VA VHA, awarded in November 2022, which provides a streamlined procurement vehicle for the VA to obtain Novocure's Optune cancer treatment technologies and services. The contract supports the VA's mission of expanding veterans' access to innovative cancer therapies.

Generated 9/14/24, 10:03 AM